MILLENNIUM MANAGEMENT LLC - CUE BIOPHARMA INC ownership

CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 38 filers reported holding CUE BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$722,170
+11.3%
313,987
+76.6%
0.00%
Q2 2023$649,120
+52674.0%
177,841
-48.4%
0.00%
-100.0%
Q1 2023$1,230
+15.4%
344,612
-7.9%
0.00%0.0%
Q4 2022$1,066
-99.9%
373,982
-15.1%
0.00%0.0%
Q3 2022$982,000
-34.5%
440,383
-26.9%
0.00%0.0%
Q2 2022$1,499,000
+154.9%
602,205
+399.9%
0.00%
Q1 2022$588,000
-54.5%
120,470
+5.5%
0.00%
-100.0%
Q4 2021$1,292,000
+7.4%
114,204
+38.3%
0.00%0.0%
Q3 2021$1,203,000
-55.0%
82,553
-64.0%
0.00%
-50.0%
Q2 2021$2,672,000
+179.5%
229,333
+192.6%
0.00%
+100.0%
Q1 2021$956,000
-78.9%
78,376
-78.4%
0.00%
-66.7%
Q4 2020$4,535,000
+67.0%
362,523
+100.9%
0.00%0.0%
Q3 2020$2,716,000
-50.0%
180,465
-18.6%
0.00%
-57.1%
Q2 2020$5,431,000
+4541.9%
221,583
+1491.3%
0.01%
Q3 2019$117,000
+36.0%
13,925
+25.5%
0.00%
Q1 2019$86,00011,0980.00%
Other shareholders
CUE BIOPHARMA INC shareholders Q2 2019
NameSharesValueWeighting ↓
Prosight Management, LP 829,042$9,376,0005.61%
P.A.W. CAPITAL CORP 120,000$1,357,0001.24%
Nantahala Capital Management 2,539,700$28,724,0001.01%
Slate Path Capital LP 1,483,619$16,780,0000.88%
SANDERS MORRIS HARRIS LLC 359,113$4,416,0000.76%
APOGEM CAPITAL LLC 62,295$705,0000.46%
Robertson Stephens Wealth Management, LLC 478,500$5,411,0000.46%
Bleichroeder LP 200,000$2,262,0000.35%
ADVISORY RESEARCH INC 257,225$2,909,0000.23%
Granite Point Capital Management, L.P. 110,000$1,244,0000.21%
View complete list of CUE BIOPHARMA INC shareholders